Plus Therapeutics Ratios (2010-2025) | PSTV

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
Gross Margin (Quarter)
EBT Margin (Quarter)							-7,186.30%	-4,417.32%	-942.89%	-78.00%	-73.16%	-290.18%	-194.45%	-285.93%	-259.62%	-276.42%	-385.55%	-108.71%	-316.61%	-417.92%
EBIT Margin (Quarter)							-6,978.08%	-4,387.40%	-933.20%	-78.42%	-73.89%	-293.83%	-196.72%	-289.05%	-260.92%	-276.20%	-333.90%	-110.65%	-320.83%	-420.04%
EBITDA Margin (Quarter)							-6,978.08%	-4,387.40%	-933.20%	-78.42%	-73.89%	-293.83%	-196.72%	-289.05%	-260.92%	-276.20%	-333.90%	-110.65%	-320.83%	-420.04%
Operating Margin (Quarter)							-6,978.08%	-4,387.40%	-933.20%	-78.42%	-73.89%	-293.83%	-196.72%	-289.05%	-260.92%	-276.20%	-333.90%	-110.65%	-320.83%	-420.04%
Net Margin (Quarter)							-7,186.30%	-4,417.32%	-942.89%	-78.00%	-73.16%	-290.18%	-194.45%	-285.93%	-259.62%	-276.42%	-385.55%	-108.71%	-316.61%	-417.92%
FCF Margin (Quarter)							-5,828.77%	-1,859.84%	-1,164.03%	-146.79%	-54.75%	-146.46%	-271.50%	-96.25%	-253.71%	-86.54%	-583.10%	-417.63%	-183.04%	-461.23%
Efficiency
Inventory Average (Quarter)
Assets Average (Quarter)	15.22M	19.59M	22.79M	23.37M	23.25M	22.89M	22.19M	23.49M	19.75M	14.92M	13.74M	12.33M	8.50M	8.42M	9.10M	6.81M	9.34M	11.20M	14.51M	17.50M
Equity Average (Quarter)	6.27M	10.73M	13.35M	12.80M	12.74M	12.16M	10.54M	8.92M	4.56M	2.67M	2.64M	0.64M	-3.09M	-6.23M	-6.40M	-7.06M	-16.30M	-10.30M	4.04M	4.53M
Invested Capital (Quarter)	16.00M	18.56M	21.51M	12.44M	16.25M	11.29M	13.01M	8.05M	7.73M	7.37M	6.97M	2.63M	-1.25M	-4.33M	-1.88M	-5.66M	-23.64M	3.03M	5.05M	4.75M
Asset Utilization Ratio (Quarter)					0.13	0.09	0.03	0.01	0.04	0.17	0.50	0.66	1.09	1.03	0.63	0.86	0.56	0.47	0.36	0.30
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-10.04	-11.24	-15.08		-19.63	-25.60	-25.47	-50.20	-47.22	-13.30	-37.37	-62.23	-97.03	-136.93	-62.28	-68.42	-6.45
Debt to Equity (Quarter)	0.68	0.55	0.46	0.61	0.43	0.62	0.50	0.84	1.89	1.77	1.66	-2.95	-0.74	-0.43	-0.64	-0.37				0.19
Debt Ratio (Quarter)	0.35	0.32	0.27	0.30	0.26	0.28	0.25	0.23	0.32	0.33	0.33	0.35	0.64	0.29	0.47	0.50				0.05
Equity Ratio (Quarter)	0.52	0.57	0.60	0.49	0.60	0.46	0.49	0.27	0.17	0.19	0.20	-0.12	-0.86	-0.68	-0.74	-1.35	-1.96	0.29	0.27	0.24
Times Interest Earned (Quarter)	-10.04	-11.24	-15.08		-19.63	-25.60	-25.47	-50.20	-47.22	-13.30	-37.37	-62.23	-97.03	-136.93	-62.28	-68.42	-6.45
Dividends & Payouts
FCF Payout Ratio (Quarter)
Valuation
Enterprise Value (Quarter)	-14.45M	-17.16M	-21.28M		-21.24M	-18.09M	-20.27M	-18.12M	-12.72M	-10.89M	-11.01M	-8.55M	-0.40M	-8.44M	-4.79M	-3.61M	-9.87M	-6.88M	-16.60M	-17.46M
Return Ratios
Return on Sales (Quarter)					-0.04%	-0.06%	-0.72%	-0.44%	-0.09%	-0.01%	-0.01%	-0.03%	-0.02%	-0.03%	-0.03%	-0.03%	-0.04%	-0.01%	-0.03%	-0.04%
Return on Capital Employed (Quarter)	-139.34%	-87.66%	-89.81%		-68.09%	-94.96%	-119.44%	-169.44%	-294.80%	-479.69%	-469.92%	-829.45%	628.03%	136.01%	485.68%	168.03%	1,229.48%	-328.61%	-1,505.15%	-295.13%
Return on Assets (Quarter)	-0.01%	-0.01%	-0.01%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	-0.02%	-0.02%	-0.02%	-0.01%	-0.01%	-0.01%
Return on Equity (Quarter)	-0.02%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	-0.05%	-0.06%	-0.06%	-0.21%	0.04%	0.02%	0.02%	0.02%	0.01%	0.01%	-0.03%	-0.03%

Research Tools

Plus Therapeutics Ratios (2010-2025) | PSTV

Create an account

Sign In

Reset Password